{"podcast":{"title":"Oncology Today with Dr Neil Love","slug":"oncology-today-with-dr-neil-love-1004241","podcast_index_feed_id":1004241,"rss_url":"https://feeds.captivate.fm/oncologytoday/","website_url":"https://www.researchtopractice.com","image_url":"https://artwork.captivate.fm/464a03b3-1b7f-4b39-a2c6-e3de4b1e77b7/8YAjpM6wBeZeb3Gyb3zbR3bE.jpg","author":"Dr. Neil Love","episode_count":463,"summary":"Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.","last_synced_at":"2026-07-28T06:21:37.419138+00:00","page_url":"https://stenobird.com/podcast/oncology-today-with-dr-neil-love-1004241"},"episode":{"title":"For Oncology Nurses: Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia — Proceedings from the 2026 Annual ONS Congress","slug":"for-oncology-nurses-non-hodgkin-lymphoma-and-chronic-lymphocytic-leukemia-proceedings-from-the-2026-annual-ons-congress","published_at":"2026-07-16T17:00:00+00:00","page_url":"https://stenobird.com/podcast/oncology-today-with-dr-neil-love-1004241/for-oncology-nurses-non-hodgkin-lymphoma-and-chronic-lymphocytic-leukemia-proceedings-from-the-2026-annual-ons-congress","show_page_url":"https://stenobird.com/podcast/oncology-today-with-dr-neil-love-1004241","url":"https://oncologytoday.captivate.fm/episode/6114-ons2026-nhlcll","audio_url":"https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/7f8b6fc3-5580-413e-948b-fd4d1b6c30ea.mp3","summary":"Featuring perspectives from Dr Farrukh T Awan, Dr Brad S Kahl, Ms Robin Klebig and Ms Mollie Moran, moderated by Dr Kahl, including the following topics: Introduction: Biology of Non-Hodgkin Lymphoma (NHL) (00:00) Current Role of CD20 x CD3 Bispecific Antibodies in NHL (4:49) Role of Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma (DLBCL) (27:48) Optimal Application of Loncastuximab Tesirine for Patients with DLBCL and Follicular Lymphoma (41:43) Role of Bruton Tyrosine Kinase (BTK) Inhibitors Alone or with Anti-CD20 Antibodies for Patients with Newly Diagnosed Chronic Lymphocytic Leukemia (CLL) (1:00:43) Combining BTK Inhibitors with Bcl-2 Inhibitors (1:31:15) Current and Future Role of Noncovalent BTK Inhibitors in CLL (1:41:30) CME information and select publications","meta_description":"Featuring perspectives from Dr Farrukh T Awan, Dr Brad S Kahl, Ms Robin Klebig and Ms Mollie Moran, moderated by Dr Kahl, including the following topics:…","key_points":[],"chapters":[],"topics":[],"duration_seconds":7106,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/oncology-today-with-dr-neil-love-1004241/episodes/for-oncology-nurses-non-hodgkin-lymphoma-and-chronic-lymphocytic-leukemia-proceedings-from-the-2026-annual-ons-congress/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/oncology-today-with-dr-neil-love-1004241/for-oncology-nurses-non-hodgkin-lymphoma-and-chronic-lymphocytic-leukemia-proceedings-from-the-2026-annual-ons-congress.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}